Neumirna Therapeutics Appoints Ellen K. Donnelly as Chief Executive Officer

Contributed by: Business Wire

Logo

Tags

Professional Services

Health

Neurology

Finance

Pharmaceutical

Biotechnology

RNA-based therapies

More Like This

Anaveon Strengthens Leadership Team with Appointments of Eric Zanelli as Chief Scientific Officer and Jill Jene as Chief Business Officer

Nordic Group B.V. Through Its Subsidiary Amring Pharmaceuticals Inc., Appoints Ophthalmology Innovator, Eric D. Donnenfeld, MD as Medical Advisory Board Chair

PR Newswire associated0

ViVac Appoints Keren Leshem as Chief Executive Officer, Strengthening Leadership to Advance RNA-Lipid Nanoparticle Immunotherapy Platform

Tiziana Life Sciences Appoints New Chief Executive Officer

Daniel G. Welch (Photo: Business Wire)

Prothena Announces Appointment of Daniel G. Welch as Director and Chair Designate

Prothena Announces Board of Directors Update

Anaveon appoints Biotech Leader Thaminda Ramanayake as Chief Executive Officer

LivaNova Appoints Donald Zurbay as a New Director